Linnea

Linnea is owned by Ipsen.

Ipsen is one of the...

• CAC All-Trade;
• Forbes Global 2000 (#2000);
• SBF 120;
• Stoxx 600.

Ipsen is a company listed under the stock ticker IPN (FR).

Ipsen has a direct presence in 5 countries.

Ipsen has 4 subsidiaries including Ipsen Iberica, Ipsen North America and Ipsen UK.

View the org chart displaying its 6 main executives

Most searched biographies at Linnea

• Susanne Caspar, Chief Executive Officer
• Simone Livio, Chief Operations Officer
• Massimo Cretti, Chief Financial Officer

Popular executive movements at Ipsen

• Pascal Touchon has joined the company as Independent Director  (posted on September 4 2023).

Create your alert
to follow the executive moves at Linnea.

Ipsen has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Linnea

Social media about Linnea

• Linnea on Wikipedia, Google News & Yahoo Finance
• Linnea on LinkedIn, Twitter & YouTube

Contact by email its executives including Susanne Caspar

Call Linnea at +41 91...

View the org chart

Register to receive your alert

Report an error